Oragenics, Inc. (OGEN) vs Propanc Biopharma Inc (PPCB)
Oragenics, Inc. and Propanc Biopharma Inc are both Biotechnology companies. Oragenics, Inc. and Propanc Biopharma Inc are of similar size ($2.3M and $2.1M). Propanc Biopharma Inc trades at the lower P/E: 0.0× against 0.4×. Across the 11 metrics below, Propanc Biopharma Inc leads on 7 and Oragenics, Inc. on 4.
Valuation
Profitability
| Metric | OGEN | PPCB | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.89% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,307.07%) | (138.20%) | (57.72%) |
| Return on assets | (264.23%) | (104.68%) | (49.22%) |
| Return on invested capital | 0.00% | (116.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack